Global and United States T-Cell Immunotherapy Market Report & Forecast 2024-2031

Report ID: 1826348 | Published Date: Dec 2025 | No. of Page: 91 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Study Coverage
    1.1 T-Cell Immunotherapy Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Introduction
    1.2 Global T-Cell Immunotherapy Outlook 2017 VS 2022 VS 2028
        1.2.1 Global T-Cell Immunotherapy Market Size for the Year 2017-2028
        1.2.2 Global T-Cell Immunotherapy Market Size for the Year 2017-2028
    1.3 T-Cell Immunotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States T-Cell Immunotherapy in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of T-Cell Immunotherapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 T-Cell Immunotherapy Market Dynamics
        1.4.1 T-Cell Immunotherapy Industry Trends
        1.4.2 T-Cell Immunotherapy Market Drivers
        1.4.3 T-Cell Immunotherapy Market Challenges
        1.4.4 T-Cell Immunotherapy Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 T-Cell Immunotherapy by Type
    2.1 T-Cell Immunotherapy Market Segment by Type
        2.1.1 CAR-T
        2.1.2 TCR
        2.1.3 TIL Therapies
    2.2 Global T-Cell Immunotherapy Market Size by Type (2017, 2022 & 2028)
    2.3 Global T-Cell Immunotherapy Market Size by Type (2017-2028)
    2.4 United States T-Cell Immunotherapy Market Size by Type (2017, 2022 & 2028)
    2.5 United States T-Cell Immunotherapy Market Size by Type (2017-2028)
3 T-Cell Immunotherapy by Application
    3.1 T-Cell Immunotherapy Market Segment by Application
        3.1.1 Stomach Cancer
        3.1.2 Lung Cancer
        3.1.3 Colorectal Cancer
        3.1.4 Esophagus Cancer
        3.1.5 Pancreatic Cancer
        3.1.6 Others
    3.2 Global T-Cell Immunotherapy Market Size by Application (2017, 2022 & 2028)
    3.3 Global T-Cell Immunotherapy Market Size by Application (2017-2028)
    3.4 United States T-Cell Immunotherapy Market Size by Application (2017, 2022 & 2028)
    3.5 United States T-Cell Immunotherapy Market Size by Application (2017-2028)
4 Global T-Cell Immunotherapy Competitor Landscape by Company
    4.1 Global T-Cell Immunotherapy Market Size by Company
        4.1.1 Top Global T-Cell Immunotherapy Companies Ranked by Revenue (2021)
        4.1.2 Global T-Cell Immunotherapy Revenue by Player (2017-2022)
    4.2 Global T-Cell Immunotherapy Concentration Ratio (CR)
        4.2.1 T-Cell Immunotherapy Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of T-Cell Immunotherapy in 2021
        4.2.3 Global T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global T-Cell Immunotherapy Headquarters, Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Type
        4.3.1 Global T-Cell Immunotherapy Headquarters and Area Served
        4.3.2 Global T-Cell Immunotherapy Companies Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into T-Cell Immunotherapy Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States T-Cell Immunotherapy Market Size by Company
        4.5.1 Top T-Cell Immunotherapy Players in United States, Ranked by Revenue (2021)
        4.5.2 United States T-Cell Immunotherapy Revenue by Players (2020, 2021 & 2022)
5 Global T-Cell Immunotherapy Market Size by Region
    5.1 Global T-Cell Immunotherapy Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global T-Cell Immunotherapy Market Size by Region (2017-2028)
        5.2.1 Global T-Cell Immunotherapy Market Size by Region: 2017-2022
        5.2.2 Global T-Cell Immunotherapy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America T-Cell Immunotherapy Market Size YoY Growth 2017-2028
        6.1.2 North America T-Cell Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific T-Cell Immunotherapy Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific T-Cell Immunotherapy Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe T-Cell Immunotherapy Market Size YoY Growth 2017-2028
        6.3.2 Europe T-Cell Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America T-Cell Immunotherapy Market Size YoY Growth 2017-2028
        6.4.2 Latin America T-Cell Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa T-Cell Immunotherapy Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa T-Cell Immunotherapy Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Adaptimmune
        7.1.1 Adaptimmune Company Details
        7.1.2 Adaptimmune Business Overview
        7.1.3 Adaptimmune T-Cell Immunotherapy Introduction
        7.1.4 Adaptimmune Revenue in T-Cell Immunotherapy Business (2017-2022)
        7.1.5 Adaptimmune Recent Development
    7.2 Altor Bioscience Corporation
        7.2.1 Altor Bioscience Corporation Company Details
        7.2.2 Altor Bioscience Corporation Business Overview
        7.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Introduction
        7.2.4 Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2017-2022)
        7.2.5 Altor Bioscience Corporation Recent Development
    7.3 Cellectis
        7.3.1 Cellectis Company Details
        7.3.2 Cellectis Business Overview
        7.3.3 Cellectis T-Cell Immunotherapy Introduction
        7.3.4 Cellectis Revenue in T-Cell Immunotherapy Business (2017-2022)
        7.3.5 Cellectis Recent Development
    7.4 Juno Therapeutics
        7.4.1 Juno Therapeutics Company Details
        7.4.2 Juno Therapeutics Business Overview
        7.4.3 Juno Therapeutics T-Cell Immunotherapy Introduction
        7.4.4 Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2017-2022)
        7.4.5 Juno Therapeutics Recent Development
    7.5 Kite Pharma
        7.5.1 Kite Pharma Company Details
        7.5.2 Kite Pharma Business Overview
        7.5.3 Kite Pharma T-Cell Immunotherapy Introduction
        7.5.4 Kite Pharma Revenue in T-Cell Immunotherapy Business (2017-2022)
        7.5.5 Kite Pharma Recent Development
    7.6 Novartis
        7.6.1 Novartis Company Details
        7.6.2 Novartis Business Overview
        7.6.3 Novartis T-Cell Immunotherapy Introduction
        7.6.4 Novartis Revenue in T-Cell Immunotherapy Business (2017-2022)
        7.6.5 Novartis Recent Development
    7.7 Takara Bio
        7.7.1 Takara Bio Company Details
        7.7.2 Takara Bio Business Overview
        7.7.3 Takara Bio T-Cell Immunotherapy Introduction
        7.7.4 Takara Bio Revenue in T-Cell Immunotherapy Business (2017-2022)
        7.7.5 Takara Bio Recent Development
    7.8 Unum Therapeutics
        7.8.1 Unum Therapeutics Company Details
        7.8.2 Unum Therapeutics Business Overview
        7.8.3 Unum Therapeutics T-Cell Immunotherapy Introduction
        7.8.4 Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2017-2022)
        7.8.5 Unum Therapeutics Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. T-Cell Immunotherapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. T-Cell Immunotherapy Market Trends
    Table 3. T-Cell Immunotherapy Market Drivers
    Table 4. T-Cell Immunotherapy Market Challenges
    Table 5. T-Cell Immunotherapy Market Restraints
    Table 6. Global T-Cell Immunotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States T-Cell Immunotherapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global T-Cell Immunotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States T-Cell Immunotherapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top T-Cell Immunotherapy Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global T-Cell Immunotherapy Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global T-Cell Immunotherapy Revenue Share by Player, 2017-2022
    Table 13. Global T-Cell Immunotherapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global T-Cell Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Immunotherapy as of 2021)
    Table 15. Top Players of T-Cell Immunotherapy in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into T-Cell Immunotherapy Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top T-Cell Immunotherapy Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States T-Cell Immunotherapy Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States T-Cell Immunotherapy Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global T-Cell Immunotherapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global T-Cell Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global T-Cell Immunotherapy Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America T-Cell Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific T-Cell Immunotherapy Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe T-Cell Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa T-Cell Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa T-Cell Immunotherapy Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Adaptimmune Company Details
    Table 31. Adaptimmune Business Overview
    Table 32. Adaptimmune T-Cell Immunotherapy Product
    Table 33. Adaptimmune Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 34. Adaptimmune Recent Development
    Table 35. Altor Bioscience Corporation Company Details
    Table 36. Altor Bioscience Corporation Business Overview
    Table 37. Altor Bioscience Corporation T-Cell Immunotherapy Product
    Table 38. Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 39. Altor Bioscience Corporation Recent Development
    Table 40. Cellectis Company Details
    Table 41. Cellectis Business Overview
    Table 42. Cellectis T-Cell Immunotherapy Product
    Table 43. Cellectis Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 44. Cellectis Recent Development
    Table 45. Juno Therapeutics Company Details
    Table 46. Juno Therapeutics Business Overview
    Table 47. Juno Therapeutics T-Cell Immunotherapy Product
    Table 48. Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 49. Juno Therapeutics Recent Development
    Table 50. Kite Pharma Company Details
    Table 51. Kite Pharma Business Overview
    Table 52. Kite Pharma T-Cell Immunotherapy Product
    Table 53. Kite Pharma Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 54. Kite Pharma Recent Development
    Table 55. Novartis Company Details
    Table 56. Novartis Business Overview
    Table 57. Novartis T-Cell Immunotherapy Product
    Table 58. Novartis Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 59. Novartis Recent Development
    Table 60. Takara Bio Company Details
    Table 61. Takara Bio Business Overview
    Table 62. Takara Bio T-Cell Immunotherapy Product
    Table 63. Takara Bio Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 64. Takara Bio Recent Development
    Table 65. Unum Therapeutics Company Details
    Table 66. Unum Therapeutics Business Overview
    Table 67. Unum Therapeutics T-Cell Immunotherapy Product
    Table 68. Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2017-2022) & (US$ Million)
    Table 69. Unum Therapeutics Recent Development
    Table 70. Research Programs/Design for This Report
    Table 71. Key Data Information from Secondary Sources
    Table 72. Key Data Information from Primary Sources
List of Figures
    Figure 1. T-Cell Immunotherapy Product Picture
    Figure 2. Global T-Cell Immunotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global T-Cell Immunotherapy Market Size 2017-2028 (US$ Million)
    Figure 4. United States T-Cell Immunotherapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States T-Cell Immunotherapy Market Size 2017-2028 (US$ Million)
    Figure 6. United States T-Cell Immunotherapy Market Share in Global 2017-2028
    Figure 7. T-Cell Immunotherapy Report Years Considered
    Figure 8. Product Picture of CAR-T
    Figure 9. Product Picture of TCR
    Figure 10. Product Picture of TIL Therapies
    Figure 11. Global T-Cell Immunotherapy Market Share by Type in 2022 & 2028
    Figure 12. Global T-Cell Immunotherapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global T-Cell Immunotherapy Market Share by Type (2017-2028)
    Figure 14. United States T-Cell Immunotherapy Market Share by Type in 2022 & 2028
    Figure 15. United States T-Cell Immunotherapy Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States T-Cell Immunotherapy Market Share by Type (2017-2028)
    Figure 17. Product Picture of Stomach Cancer
    Figure 18. Product Picture of Lung Cancer
    Figure 19. Product Picture of Colorectal Cancer
    Figure 20. Product Picture of Esophagus Cancer
    Figure 21. Product Picture of Pancreatic Cancer
    Figure 22. Product Picture of Others
    Figure 23. Global T-Cell Immunotherapy Market Share by Application in 2022 & 2028
    Figure 24. Global T-Cell Immunotherapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global T-Cell Immunotherapy Market Share by Application (2017-2028)
    Figure 26. United States T-Cell Immunotherapy Market Share by Application in 2022 & 2028
    Figure 27. United States T-Cell Immunotherapy Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States T-Cell Immunotherapy Market Share by Application (2017-2028)
    Figure 29. North America T-Cell Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe T-Cell Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific T-Cell Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America T-Cell Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa T-Cell Immunotherapy Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. U.A.E T-Cell Immunotherapy Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Adaptimmune Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022)
    Figure 58. Altor Bioscience Corporation Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022)
    Figure 59. Cellectis Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022)
    Figure 60. Juno Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022)
    Figure 61. Kite Pharma Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022)
    Figure 62. Novartis Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022)
    Figure 63. Takara Bio Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022)
    Figure 64. Unum Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
Frequently Asked Questions
T-Cell Immunotherapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
T-Cell Immunotherapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
T-Cell Immunotherapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Womens Cosmetics

Womens Cosmetics market is segmented by region (country), players, by Type and by Application. Pl ... Read More

All-Season Tents

All-Season Tents market is segmented by region (country), players, by Type and by Application. Pl ... Read More

Aromatherapy Oil

Aromatherapy Oil market is segmented by region (country), players, by Type and by Application. Pl ... Read More